CRISPR Therapeutics AG (CRSP)
51.72
-0.54
(-1.03%)
USD |
NASDAQ |
Sep 11, 16:00
51.50
-0.22
(-0.43%)
After-Hours: 07:35
CRISPR Therapeutics Price : 51.72 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 52.35 | 53.21 | 51.62 | 51.72 | 856711.0 |
| Sep 10, 2026 | 52.50 | 52.62 | 51.72 | 52.26 | 1.262M |
| Sep 09, 2026 | 54.60 | 54.90 | 53.31 | 53.45 | 1.185M |
| Sep 08, 2026 | 54.45 | 55.10 | 52.78 | 54.78 | 1.386M |
| Sep 04, 2026 | 56.06 | 57.21 | 55.35 | 55.79 | 904292.0 |
| Sep 03, 2026 | 57.50 | 57.80 | 55.72 | 56.49 | 1.491M |
| Sep 02, 2026 | 57.13 | 58.96 | 55.59 | 56.92 | 911120.0 |
| Sep 01, 2026 | 56.22 | 57.13 | 55.43 | 56.82 | 890824.0 |
| Aug 31, 2026 | 56.55 | 57.49 | 56.20 | 56.98 | 1.391M |
| Aug 28, 2026 | 58.22 | 59.37 | 57.10 | 57.72 | 1.389M |
| Aug 27, 2026 | 59.12 | 60.11 | 58.02 | 59.37 | 1.189M |
| Aug 26, 2026 | 60.18 | 60.39 | 58.06 | 59.23 | 959931.0 |
| Aug 25, 2026 | 57.93 | 61.55 | 57.51 | 60.90 | 2.084M |
| Aug 24, 2026 | 58.75 | 58.96 | 56.62 | 57.08 | 1.120M |
| Aug 21, 2026 | 59.72 | 62.54 | 58.89 | 59.50 | 2.454M |
| Aug 20, 2026 | 58.73 | 60.90 | 56.94 | 58.12 | 2.910M |
| Aug 19, 2026 | 55.00 | 59.92 | 54.98 | 59.81 | 3.843M |
| Aug 18, 2026 | 53.20 | 53.88 | 51.80 | 52.97 | 1.314M |
| Aug 17, 2026 | 53.08 | 54.57 | 52.61 | 54.28 | 958154.0 |
| Aug 14, 2026 | 53.99 | 54.00 | 52.23 | 53.55 | 807993.0 |
| Aug 13, 2026 | 54.28 | 54.70 | 53.50 | 53.99 | 909129.0 |
| Aug 12, 2026 | 54.30 | 55.02 | 53.46 | 53.99 | 742904.0 |
| Aug 11, 2026 | 53.88 | 54.68 | 53.12 | 54.07 | 1.066M |
| Aug 10, 2026 | 53.50 | 54.68 | 53.10 | 53.51 | 1.187M |
| Aug 07, 2026 | 52.58 | 54.17 | 52.18 | 53.52 | 1.284M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 515.44 |
| Basilea Pharmaceutica AG | 77.40 |
| Santhera Pharmaceuticals Holding AG | 19.79 |
| BeOne Medicines Ltd. | 346.51 |
| AC Immune SA | 2.76 |
Price Related Metrics
| PS Ratio | 366.06 |
| Price to Book Value | 2.862 |
| Earnings Yield | -9.21% |
| Market Cap | 4.999B |